Product/Composition:- | Doxorubicin Liposomal |
---|---|
Strength:- | 20 mg/10 mL (2 mg/mL), 50 mg/25 mL (2 mg/mL) |
Form:- | Liposomal Injection ( |
Reference Brands:- | Doxil® , Caelyx® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Doxorubicin Liposomal, sold as Doxil® (US) and Caelyx® (EU), is used for breast cancer, ovarian cancer, Kaposi’s sarcoma, and multiple myeloma. The liposomal formulation targets tumors more effectively, reducing systemic toxicity. Available in 20 mg/10 mL and 50 mg/25 mL concentrations, it is provided in single-use vials. Trusted by oncologists, it offers effective cancer treatment with minimized side effects in US and EU markets.
Doxorubicin Liposomal, marketed as Doxil® (US) and Caelyx® (EU), is a chemotherapy agent used to treat breast cancer, ovarian cancer, Kaposi’s sarcoma, and multiple myeloma. Its liposomal formulation encapsulates the doxorubicin drug, allowing for more targeted delivery and reduced systemic toxicity compared to conventional doxorubicin. Available in 20 mg/10 mL and 50 mg/25 mL concentrations, it is supplied in single-use vials for oncology treatment. Sourced from GMP-compliant manufacturers, Doxorubicin Liposomal offers effective treatment for cancer patients while minimizing side effects, making it a trusted choice for healthcare providers in US and EU markets.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications